CompanyPrivateBoston, MA

Crosslink Therapeutics Inc

SEC EDGAR ClinicalTrials.gov

DOct 20Latest SEC filing

Form DMay 15$4.3M sold

October 2026

Crosslink Therapeutics files Form D for $5.5 million offering

Oct 20FinancingCrosslink Therapeutics Inc